Baite Medical has completed nearly 100 million yuan in Series B financing.

On March 16, according to Kai Sheng Capital, Shenzhen Bai Te Wei Medical Technology Co., Ltd. recently announced the completion of nearly 100 million RMB Series B financing. The round was led by Tianjin Tasly Capital with Qinzhi Capital as a co-investor, and Kai Sheng Capital as the exclusive financial advisor. This round of financing will be mainly used for new product research and development, construction of production bases, and market expansion, accelerating the company's innovative product layout in the fields of peripheral vascular intervention and heart failure.